OUTCOMES OF OXALIPLATIN- BASED ADJUVANT CHEMOTHERAPY IN HIGH-RISK STAGE II AND STAGE III COLON CANCER: A RETROSPECTIVE STUDY AT HANOI MEDICAL UNIVERSITY HOSPITAL. Vietnam Journal of Community Medicine, v. 67, n. 10, 30 Oct.2026.